News | May 11, 2024
Ami Organics posts Q4 FY24 consolidated profit at Rs. 25.14 Cr
Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024
Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024
The Gold Medal distinction places the company in the top 5% of all organizations assessed within EcoVadis's rigorous framework globally
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Ami Organics recently announced contract with global MNC for manufacturing of electrolyte for battery cells
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
The product is expected to start contributing meaningfully to the revenue from FY25
The company has successfully developed Methyl salicylate using Flow Chemistry and successfully erected a Flow reactor at Jhagadia plant and expects to start production from Q3 FY23
The plant is expected to start commercial operations from Q4FY24
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)